Results 111 to 120 of about 60,905 (219)

Carbapenem resistance in community-acquired urinary tract infections caused by <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i> in Morocco: a multicentre study (January 2022-December 2023): '<b>Carbapenem resistance in community UTIs in Morocco'</b>. [PDF]

JAC Antimicrob Resist
Khazaz A, El Otmani F, Benzaarate I, Bourjilat F, El Hamouchi A, Rafetrarivony LF, Huynh BT, Crucitti T, Brisse S, Nayme K.   +9 more
europepmc   +1 more source

No improvement in clinical outcomes: a propensity score analysis of inappropriate carbapenem use in children with susceptible <i>Escherichia coli</i> bloodstream infections. [PDF]

Front Cell Infect Microbiol
Zhang Q, Liu Y, Huo J, Pu K, Tan L, Cheng J.   +5 more
europepmc   +1 more source

Effect of a multimodal intervention in general and digestive surgery wards on carbapenem use and antimicrobial resistance: protocol for a prospective, quasi-experimental interrupted time-series study. [PDF]

BMJ Open
Vazquez-Piqueras N, Padullés A, Sabé N, Shaw E, Abelenda-Alonso G, Suárez-Lledó A, Costa RM, Peláez N, Molina Molina GJ, Dordal MT, Andres B, Jiménez-Martínez E, Laguna MDM, Peñafiel J, Carratalà J, Oriol I.   +15 more
europepmc   +1 more source

Mechanisms of resistance to the carbapenems [PDF]

Journal of Antimicrobial Chemotherapy, 1995
D, Livingstone, M J, Gill, R, Wise
openaire   +2 more sources

The synergistic action of reduced membrane permeability and antibiotic sequestration as a novel mechanism for carbapenem resistance in <i>Campylobacter</i>. [PDF]

mBio
Chen X, Zhou Y, Zhou Q, He M, Zhao M, Dai S, Li J, Hou C, Tao W, Yang X, Lan S, Yang X, Lei C, Zhang A, Wang H, Tang Y.   +15 more
europepmc   +1 more source

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis. [PDF]

Emerg Microbes Infect
Dortet L, Moreau C, Dinh A, Bonnin RA, Escaut L, Seguret M, Weber L, Figueiredo S, Pilmis B.   +8 more
europepmc   +1 more source

Increase in bla_NDM among Carbapenemase-Producing, Carbapenem-Resistant Enterobacterales, United States, 2016-2023. [PDF]

Emerg Infect Dis
Ansari UA, Campbell D, Brandenburg JM, Duffy N, Grass JE, Guh AY, Lutgring JD, Elkins CA, Karlsson M, Gargis AS, HAIC MuGSI Working Group.   +10 more
europepmc   +1 more source

Ventilator-Associated Pneumonia Due to ESBL-Producing Escherichia coli Successfully Treated with Cefepime/Enmetazobactam: A European Case Report. [PDF]

Infect Dis Ther
Viaggi B, Giani T, Palomba E, Gori A, Farese A, Rossolini GM, Colaneri M.   +6 more
europepmc   +1 more source

Clinical Risk Factors and Outcomes of Carbapenem-Resistant P<i>seudomonas aeruginosa</i> Nosocomial Infections in a Tertiary Hospital in China: A Retrospective Study from 2016 to 2023. [PDF]

Infect Drug Resist
Li X, Zhang T, Liu T, Xiang F, Sun G, Tian J, Zhang M, Zhong Z.   +7 more
europepmc   +1 more source

Genomic and Phenotypic Insights into Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> in the Aquatic Environments of the Tibetan Plateau. [PDF]

Microorganisms
Lu D, Liu L, Yang Z, Chen T, Yang D, Shi D, Zhou S, Li J, Li H, Jin M.   +9 more
europepmc   +1 more source